Gustavo Baldassarre

32PUBLICATIONS
100CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyNutrigenomics and personalised nutritionPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 02, 2026
CDK12/13 inhibition overcomes platinum resistance by impairing RNA metabolism.

|Apr 29, 2026
Fra-2 controls the response to the KRAS inhibitor MRTX-1133 in pancreatic ductal adenocarcinoma.

|Mar 28, 2026
Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer.

Rita Lombardi, Laura Addi, Biagio Pucci

|Nov 28, 2025
The future of gynecologic oncologic surgery: a narrative review of current surgical trials.

Stefano Fucina, Claudio Reato, Anna Del Fabro

|Aug 06, 2025
Quality of radiation shapes survival, invasiveness, and migration in ovarian cancer cell lines with different molecular profiles and varying alpha/beta ratios: an in vitro study on behalf of the Multicenter Italian Trials in Ovarian Cancer (MITO) group.

Amelia Barcellini, Alexandra Charalampopoulou, Gustavo Baldassarre

|Nov 13, 2024
USP1 deubiquitinates PARP1 to regulate its trapping and PARylation activity.

Anna Nespolo, Linda Stefenatti, Ilenia Pellarin

Pageof 6

Frequent Collaborators

19 joint publications

Barbara Belletti

9 joint publications

Monica Schiappacassi

5 joint publications

Gian Luca Rampioni Vinciguerra

5 joint publications

Maura Sonego